Pieter van der Velden

Principal Investigator
Leiden University Medical Center
Pieter holds a position at the LUMC in the department of Ophthalmology as PI in the field of uveal melanoma genetics. By applying the most recent technical advances, the heterogeneity of UM is studied. Genetic and cellular heterogeneity provides information on molecular pathogenesis and may ultimately offer chances for treatment. Pieter is part of UM Cure, an European consortium of preclinical researchers that aims to provide treatment for metastatic uveal melanoma


November 8 2019, 14:00
 - 14:30
Digital PCR For The Molecular Analysis Of Uveal Melanoma

Live Webinar

Higher Quality Nucleic Acid Extraction from FFPE Tissue & Other Challenging Samples Using the Ionicâ„¢ Purification System

hosted by Klint Rose, Chief Scientific Officer, Purigen Biosystems

Wednesday 27th May
16:00 BST